Haemonetics Corporation

NYSE:HAE

Sector

🏥 Health Care

Industries

🏥 Hospitals & Clinics

💳 Credit Cards & Payments

🩺 Medical Instruments

💻 Telehealth

Location

United States

Market Cap

USD 3.61 B

Share Price

USD 75.20

Avg Daily Volume

579,243

Change (1 day)

1.27%

Change (1 year)

-17.00%

Change (YTD)

-3.69%

Haemonetics Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 29, 2025: USD 87.38 M

Haemonetics Corporation Depreciation And Amortization is USD 87.38 M for the Trailing 12 Months (TTM) ending March 29, 2025, a -10.12% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.

Haemonetics Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 30, 2024 was USD 97.22 M, a 4.19% change year over year.
Haemonetics Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending April 01, 2023 was USD 93.31 M, a -4.54% change year over year.
Haemonetics Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending April 02, 2022 was USD 97.75 M, a 15.97% change year over year.
Haemonetics Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending April 03, 2021 was USD 84.29 M, a -23.58% change year over year.